Chimeric composite skin substitutes for delivery of autologous keratinocytes to promote tissue regeneration

Annals of Surgery

Volumn 251, Issue 2, 2010, Pages 368-376

  Rasmussen, Cathy A ^a   Gibson, Angela L ^a   Schlosser, Sandy J ^a   Schurr, Michael J ^a   Allen Hoffmann, B Lynn ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL JUNCTION; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; KERATINOCYTE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CULTURE; SKIN FUNCTION; SKIN INJURY; SKIN TRANSPLANTATION; SQUAMOUS EPITHELIUM; TISSUE REGENERATION; WOUND CLOSURE; ANIMAL; CELL CULTURE; CELL LINE; CHIMERA; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; METHODOLOGY; NUDE MOUSE; REGENERATION; TISSUE ENGINEERING; TRANSPLANTATION;

ANIMALS; CELL LINE; CELLS, CULTURED; CHIMERA; HUMANS; KERATINOCYTES; MICE; MICE, NUDE; REGENERATION; SKIN PHYSIOLOGICAL PHENOMENA; SKIN TRANSPLANTATION; TISSUE ENGINEERING;

EID: 77449121849     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181c1ab5f     Document Type: Article

References (28)

1. Atiyeh BS, Costagliola M. Cultured epithelial autograft (CEA) in burn treatment: three decades later. Burns. 2007;33:405-413.
2. Nemes Z, Steinert PM. Bricks and mortar of the epidermal barrier. Exp Mol Med. 1999;31:5-19.
3. Cairns BA, deSerres S, Peterson HD, et al. Skin replacements: the biotech-nological quest for optimal wound closure. Arch Surg. 1993;128:1246-1252.
4. Suzuki T, Ui K, Shioya N, et al. Mixed cultures comprising syngeneic and allogeneic mouse keratinocytes as a graftable skin substitute. Transplantation. 1995;59:1236-1241.
5. Rouabhia M. Permanent skin replacement using chimeric epithelial cultured sheets comprising xenogeneic and syngeneic keratinocytes. Transplantation. 1996;61:1290-1300. (Pubitemid 26152815)
6. Mansbridge JN. Tissue-engineered skin substitutes in regenerative medicine. Curr opin in Biotechnol. 2009; epub.
7. Griffith LG, Naughton G. Tissue engineering-current challenges and expanding opportunities. Science. 2002;295:1009-1014.
8. Allen-Hoffmann BL, Schlosser SJ, Ivarie CA, et al. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratin-ocyte cell line, NIKS. J Invest Dermatol. 2000;114:444-455.
9. Schurr MJ, Foster KN, Centanni JM, et al. Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute. J Trauma. 2009;66:866-874.
10. Allen-Hoffmann BL, Rheinwald JG. Polycyclic aromatic hydrocarbon mu-tagenesis of human epidermal keratinocytes in culture. Proc Natl Acad Sci USA. 1984;81:7802-7806.
11. Liliensiek SJ. Investigation into the Role of the Defender Against Apoptotic Death Protein (DAD1) in Keratinocyte Differentiation and Survival. Cellular and Molecular Pathology, Doctor of Philosophy. Madison, WI: University of Wisconsin; 2002:304.
12. Gabard B, Treffel P. Hardware and measuring principle: the nova DPM 9003. In: Elsner P, Berardesca E, Maibach HI, eds. Bioengineering of the Skin: Water and the Stratum Corneum. Boca Raton, FL: CRC Press; 1994:177-195.
13. Pinkus H. Examination of the epidermis by the strip method of removing horny layers: part I. Observations on thickness of the horny layer, and on mitotic activity after stripping. J Invest Dermatol. 1951;16:383-386.
14. van der Valk PG, Maibach HI. A functional study of the skin barrier to evaporative water loss by means of repeated cellophane-tape stripping. Clin Exp Dermatol. 1990;15:180-182.
15. Boyce ST, Medrano EE, Abdel-Malek Z, et al. Pigmentation and inhibition of wound contraction by cultured skin substitutes with adult mela-nocytes after transplantation to athymic mice. J Invest Dermatol. 1993; 100:360-365.
16. Daar AS, Fuggle SV, Fabre JW, et al. The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation. 1984;38:287-292.
17. Larochelle F, Ross G, Rouabhia M. Permanent skin replacement using engineered epidermis containing fewer than 5% syngeneic keratinocytes. Lab Invest. 1998;78:1089-1099.
18. Clayton E, Doupe DP, Klein AM, et al. A single type of progenitor cell maintains normal epidermis. Nature. 2007;446:185-189.
19. Jones PH, Simons BD, Watt FM. Sic transit gloria: farewell to the epidermal transit amplifying cell? Cell Stem Cell. 2007;1:371-381.
20. Krishnan M, Park JM, Cao F, et al. Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. FASEB J. 2006;20:106-108.
21. Eaglstein WH, Alvarez OM, Auletta M, et al. Acute excisional wounds treated with a tissue-engineered skin (Apligraf). Dermatol Surg. 1999;25: 195-201.
22. Phillips TJ, Manzoor J, Rojas A, et al. The longevity of a bilayered skin substitute after application to venous ulcers. Arch Dermatol. 2002;138:1079-1081.
23. Hu S, Kirsner RS, Falanga V, et al. Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study. Wound Repair Regen. 2006;14:427-433.
24. Sheridan RL, Tompkins RG. Skin substitutes in burns. Burns. 1999;25:97-103.
25. Vogt PM, Thompson S, Andree C, et al. Genetically modified keratinocytes transplanted to wounds reconstitute the epidermis. Proc Natl Acad Sci USA. 1994;91:9307-9311.
26. Supp DM, Supp AP, Bell SM, et al. Enhanced vascularization of cultured skin substitutes genetically modified to overexpress vascular endothelial growth factor. J Invest Dermatol. 2000;114:5-13.
27. Thomas-Virnig CL, Centanni JM, Johnston CE, et al. Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue. Mol Ther. 2009;17:562-569.
28. Steinstraesser L, Al-Benna S, Kesting M, et al. Bioengineered human skin: working the bugs out. Mol Ther. 2009;17:405-408